VitriVax, Inc.

VitriVax, Inc.

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://vitrivaxbio.com

Last Round

Series B

Oct 22, 2025

Total Funding Raised

$80.5M

Company Overview

VitriVax, Inc. is a biotechnology company developing a vaccine formulation platform (ALTA®) that makes vaccines thermostable and enables single-shot administration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Advanced Materials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

thermostable vaccinessingle-shot vaccinesvaccine formulationcold chain free vaccinesvaccine deliveryALTA platformvaccine stabilitytimed-release deliveryanimal healthspray dryingatomic layer depositionglobal public healthgovernment contractsCDMO services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VitriVax, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VitriVax, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BOct 22, 2025
GrantOct 14, 2025
GrantSep 14, 2025
GrantApr 28, 2025
GrantDec 4, 2024
Grant
Dec 6, 2023

Key People

Founding team and executive leadership

Romulo Colindres

Chief Executive Officer

Executive Team

VitriVax, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 22, 2025

    $17.25M round closed.

  • Sep 14, 2025

    Secured $10M in grant funding.

VitriVax, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VitriVax, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VitriVax, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range51
Year Founded2014
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.